Screening for Chronic Kidney Disease in HIV-Infected Patients
- 31 January 2010
- journal article
- review article
- Published by Elsevier BV in Advances in Chronic Kidney Disease
- Vol. 17 (1), 26-35
- https://doi.org/10.1053/j.ackd.2009.07.014
Abstract
With improved survival afforded by highly active antiretroviral therapy (HAART), CKD has emerged as one of the primary comorbid conditions affecting HIV-infected individuals. Although CKD in HIV-infected individuals is classically thought of as a consequence of advanced HIV infection such as in the case of HIV-associated nephropathy, several factors likely contribute to the development CKD in HIV infection. These factors include genetic predisposition, age-related decline in kidney function, HAART-related metabolic changes, exposure to multiple nephrotoxic medications, and concurrent conditions such as hepatitis C or illicit drug use. Similar to the general population, proteinuria and impaired kidney function are associated with faster progression to acquired immune deficiency syndrome and death. Given the prevalence and impact of kidney disease on the course of HIV infection and its management, current guidelines recommend screening all HIV-infected individuals for kidney disease. This review focuses on the current guidelines for kidney disease screening and discusses traditional as well as promising strategies for detecting CKD in this vulnerable population.Keywords
This publication has 89 references indexed in Scilit:
- Iron-Related ProteinsClinical Journal of the American Society of Nephrology, 2009
- Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney DiseaseClinical Journal of the American Society of Nephrology, 2009
- Interruption of antiretroviral therapy is associated with increased plasma cystatin CAIDS, 2009
- Influence of Muscle Mass and Physical Activity on Serum and Urinary Creatinine and Serum Cystatin CClinical Journal of the American Society of Nephrology, 2008
- Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKDAmerican Journal of Kidney Diseases, 2008
- Decreased serum lipocalin-2 levels in human immunodeficiency virus-infected patients: increase during highly active anti-retroviral therapyClinical and Experimental Immunology, 2008
- Low Rates of Antiretroviral Therapy among HIV-Infected Patients with Chronic Kidney DiseaseClinical Infectious Diseases, 2007
- Cystatin C Level as a Marker of Kidney Function in Human Immunodeficiency Virus InfectionThe FRAM StudyArchives of Internal Medicine, 2007
- Use of Single Voided Urine Samples to Estimate Quantitative ProteinuriaNew England Journal of Medicine, 1983
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976